Moors & Cabot Inc. decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 33.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,637 shares of the exchange traded fund’s stock after selling 2,300 shares during the quarter. Moors & Cabot Inc.’s holdings in SPDR S&P Biotech ETF were worth $458,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Tidemark LLC raised its stake in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $40,000. ORG Partners LLC acquired a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $40,000. ORG Wealth Partners LLC purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $44,000. Finally, Howe & Rusling Inc. purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $49,000.
SPDR S&P Biotech ETF Trading Up 2.1 %
NYSEARCA XBI opened at $96.24 on Friday. SPDR S&P Biotech ETF has a 12-month low of $71.99 and a 12-month high of $105.47. The company has a fifty day simple moving average of $98.44 and a two-hundred day simple moving average of $96.23. The stock has a market cap of $7.34 billion, a P/E ratio of 11.47 and a beta of 1.11.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- About the Markup Calculator
- Tesla Investors Continue to Profit From the Trump Trade
- Profitably Trade Stocks at 52-Week Highs
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What is the Dow Jones Industrial Average (DJIA)?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.